CN Patent

CN119585268A — 制备杂芳基-酮稠合的氮杂萘烷糖皮质激素受体调节剂的方法

Assigned to Corcept Therapeutics Inc · Expires 2025-03-07 · 1y expired

What this patent protects

本发明提供了制备杂芳基‑酮稠合的氮杂萘烷糖皮质激素受体调节剂的方法，以及具有低杂质水平的组合物。

USPTO Abstract

本发明提供了制备杂芳基‑酮稠合的氮杂萘烷糖皮质激素受体调节剂的方法，以及具有低杂质水平的组合物。

Drugs covered by this patent

Mifeprex (MIFEPRISTONE) · Corcept Therap

Patent Metadata

Patent number: CN119585268A
Jurisdiction: CN
Classification: —
Expires: 2025-03-07
Drug substance claim: No
Drug product claim: No
Assignee: Corcept Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.